Literature DB >> 1331535

The herpes simplex virus type 1 (HSV-1) a sequence serves as a cleavage/packaging signal but does not drive recombinational genome isomerization when it is inserted into the HSV-2 genome.

J R Smiley1, C Lavery, M Howes.   

Abstract

We inserted the terminal repeat (a sequence) of herpes simplex virus type 1 (HSV-1) strain KOS into the tk gene of HSV-2 strain HG52 in order to assess the ability of the HSV-1 a sequence to provoke genome isomerization events in an HSV-2 background. We found that the HSV-1 a sequence was cleaved by the HSV-2 cleavage/packaging machinery to give rise to novel genomic termini. However, the HSV-1 a sequence did not detectably recombine with the HSV-2 a sequence. These results demonstrate that the viral DNA cleavage/packaging system contributes to a subset of genome isomerization events and indicate that the additional recombinational inversion events that occur during infection require sequence homology between the recombination partners.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331535      PMCID: PMC240459     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Origin of two different classes of defective HSV-1 Angelotti DNA.

Authors:  H C Kaerner; I B Maichle; A Ott; C H Schröder
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

2.  Terminal repetitive sequences in herpesvirus saimiri virion DNA.

Authors:  A T Bankier; W Dietrich; R Baer; B G Barrell; F Colbère-Garapin; B Fleckenstein; W Bodemer
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

3.  A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection.

Authors:  K L Poffenberger; B Roizman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences.

Authors:  S L Varmuza; J R Smiley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene.

Authors:  R Longnecker; B Roizman
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

8.  Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity.

Authors:  P C Weber; M D Challberg; N J Nelson; M Levine; J C Glorioso
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

9.  Sequence requirements for DNA rearrangements induced by the terminal repeat of herpes simplex virus type 1 KOS DNA.

Authors:  J R Smiley; J Duncan; M Howes
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

10.  Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1.

Authors:  W Hammerschmidt; H Ludwig; H J Buhk
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  16 in total

1.  Machinery to support genome segment inversion exists in a herpesvirus which does not naturally contain invertible elements.

Authors:  M A McVoy; D Ramnarain
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Effects of mutations within the herpes simplex virus type 1 DNA encapsidation signal on packaging efficiency.

Authors:  P D Hodge; N D Stow
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Herpes simplex virus genome isomerization: origins of adjacent long segments in concatemeric viral DNA.

Authors:  B Slobedman; X Zhang; A Simmons
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates.

Authors:  R Martinez; R T Sarisky; P C Weber; S K Weller
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  An enhanced packaging system for helper-dependent herpes simplex virus vectors.

Authors:  T A Stavropoulos; C A Strathdee
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  A human cytomegalovirus deleted of internal repeats replicates with near wild type efficiency but fails to undergo genome isomerization.

Authors:  Anne Sauer; Jian Ben Wang; Gabriele Hahn; Michael A McVoy
Journal:  Virology       Date:  2010-03-07       Impact factor: 3.616

7.  Herpes simplex virus type 1 recombination: the Uc-DR1 region is required for high-level a-sequence-mediated recombination.

Authors:  R E Dutch; B V Zemelman; I R Lehman
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA.

Authors:  J Zimmermann; W Hammerschmidt
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Excision of DNA fragments corresponding to the unit-length a sequence of herpes simplex virus type 1 and terminus variation predominate on one side of the excised fragment.

Authors:  K Umene
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Herpes simplex virus type 1 variant a sequence generated by recombination and breakage of the a sequence in defined regions, including the one involved in recombination.

Authors:  K Umene
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.